1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid- resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1)

Blood

Volumn 93, Issue 7, 1999, Pages 2225-2233

  Muto, Akihiro ^b   Kizaki, Masahiro ^a   Yamato, Kenji ^b   Kawai, Yohko ^b   Kamata Matsushita, Maiko ^b   Ueno, Hironori ^b   Ohguchi, Masahiro ^b   Nishihara, Tatsuji ^b   Koeffler, H Phillip ^b   Ikeda, Yasuo ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; PROTEIN P21; PROTEIN P27; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; DOSE TIME EFFECT RELATION; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0033121122     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.7.2225.407a05_2225_2233     Document Type: Article

References (47)

1. Lotan R: Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605:33, 1980
2. Douer D, Koeffler HP: Retinoic acid enhances growth of human early progenitor cells in vitro. J Clin Invest 69:1039, 1982
3. Koeffler HP: Induction of differentiation of human acute myelogenous leukemia cells: Therapeutic implications. Blood 62:709, 1983
4. Breitman TR, Selonick SE, Collins SJ: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936, 1980
5. Sakashita A, Kizaki M, Pakkala S, Schiller G, Tsuruoka N, Tanosaki R, Cameron JF, Dawson MI, Koeffler HP: 9-cis-Retinoic acid: Effects on normal and leukemic hematopoiesis in vitro. Blood 81:1009, 1993
6. Kizaki M, Ikeda Y, Tanosaki R, Nakajima H, Morikawa M, Sakashita A, Koeffler HP: Effects of novel retinoic acid compound, 9-cis-retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptor-α and retinoid X receptor-α RNA by HL-60 cells. Blood 82:3592, 1993
7. 3. Proc Natl Acad Sci USA 78:4990, 1981
8. 3 prolongs survival time of leukemic mice. Proc Natl Acad Sci USA 87:3929, 1990
9. Evans RM: The steroid and thyroid receptor superfamily. Science 240:889, 1988
10. Giguere V, Ong ES, Segui P, Evans RM: Identification of a receptor for the morphogen retinoic acid. Nature 330:624, 1987
11. Petkovick M, Brand NJ, Krust A, Chambon P: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330:444, 1987
12. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW: Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85:3294, 1988
13. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin J-M, Glass CK, Rosenfeld MG: RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251, 1991
14. Bugge TH, Pohl J, Lonnoy O, Stunnenberg HG: RXRα, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J 11:1409, 1992
15. 3 signaling. Nature 355:446, 1992
16. Jiang H, Lin J, Su Z, Collart FR, Huberman E, Fisher PB: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397, 1994
17. WAF1/CIP1/SDI1 in differentiating human leukemic cells. J Clin Invest 95:973, 1995
18. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142, 1996
19. 3 in HL-60 cells. Cancer Res 56:264, 1996
20. Huang ME, Ye UC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu HT, Wang ZY: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
21. Castaigne S, Chomienne C, Daniel MT, Ballarini P, Berger R, Fenaux P, Degos L: All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704, 1990
22. Warrell RP Jr, Frankel SR, Miller WH Jr, Sheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrovski E: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385, 1991
23. Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, Hiraoka H, Yamada O, Oh H, Saito K, Matsuda S, Minato K, Ueda T, Ohno R: All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 85:1202, 1995
24. Warrell RP Jr, de The H, Wang ZY, Degos L: Acute promyelocytic leukemia. N Engl J Med 329:177, 1993
25. Kizaki M, Matsushita H, Takayama N, Muto A, Ueno H, Awaya N, Kawai Y, Asou H, Kamada N, Ikeda Y: Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features. Blood 88:1824, 1996
26. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R: NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080, 1991
27. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817, 1993
28. Kip1, a cyclin-cdk inhibitor and a potential mediator of extracellular antimitogenetic signals. Cell 78:59, 1994
29. 3 synergize with 12-O-tetradecanoylphorbol-13-acetate to induce macrophage differentiation in acute promyelocytic leukemia NB4 cells. Leukemia 8:1744, 1994
30. 3. Cancer Res 54:4508, 1994
31. Warrell RP Jr: Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies, and implications. Blood 82: 1949, 1993
32. Kizaki M, Ueno H, Yamazoe Y, Shimada M, Takayama N, Muto A, Matsushita H, Nakajima H, Morikawa M, Koeffler HP, Ikeda Y: Mechanisms of retinoid resistance in leukemic cells: Possible role of cytochrome P450 and P-glycoprotein. Blood 87:725, 1996
33. Furukawa Y, Uenoyama S, Ohta M, Tsunoda A, Griffin JD, Saito M: Transforming growth factor-β inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line Josk-1. J Biol Chem 267:17121, 1992
34. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travali S, Deisseroth AB, Mercer WE: p53-Independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 55:668, 1995
35. 3 is independent of nuclear receptor binding. J Biol Chem 270:15962, 1995
36. kip1. Genes Dev 11:2335, 1997
37. Imaizumi M, Suzuki H, Yoshinari M, Sato A, Saito T, Sugawara A, Tsuchiya S, Hatae Y, Fujimoto T, Kakizuka A, Konno T, Iinuma K: Mutations in the E-domain of RARα portion of the PML/RARα chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia. Blood 92:374, 1998
38. Ding W, Li Y-P, Nobile LM, Grills G, Carrera I, Paietta E, Tallman MS, Wiernik PH, Gallagher RE: Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARα fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. Blood 92:1172, 1998
39. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr, Evans RM: Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391:811, 1998
40. Grignani F, Matteis SD, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Lazar MA, Minucci S, Pellicci PG: Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia. Nature 391:815, 1998
41. He L-Z, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP: Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nat Genet 18:126, 1998
42. Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S, Zelent A: Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARα underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91:2634, 1998
43. WAF1/CP1 gene by retinoic acid receptor. J Biol Chem 271:31723, 1996
44. 3-induced monocytic differentiation of U937 cells. Leuk Res 20:665, 1996
45. 3 is associated with the expression of retinoid X receptor α. Biochem Biophys Res Commun 203:272, 1994
46. 3/retinoic acid induction of human promyelocytic cell lines: Enhanced phagocytic cell maturation and hybrid granulocytic phenotype. Cell Growth Differ 6:493, 1995
47. 3 analogs and 9-cis retinoic acid. J Clin Invest 99:349, 1997